Antidepressants and Sexual Dysfunction: Mechanisms and Clinical Implications

References

• . American Psychiatric Association. Mood disorders. In: American Psychiatric Association Task Force on DSM-IV, ed. Diagnostic and Statistical Manual of Mental Disorders, 4th ed, text revision [DSM-IV-TR]. Washington, DC: American Psychiatric Association; 2000:345–428
   Google Scholar
• . Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R). Arch Gen Psychiatry. 2005;62(6):617–627
   PubMed Web of Science ®Google Scholar
• . Kessler RC, Berglund P, Demler O, . The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095–3105
   PubMed Web of Science ®Google Scholar
• . Mojtabai R, Olfson M. Proportion of antidepressants prescribed without a psychiatric diagnosis is growing. Health Aff (Millwood). 2011;30(8):1434–1442
   PubMed Web of Science ®Google Scholar
• . Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281(6):537–544
   PubMed Web of Science ®Google Scholar
• . Laumann EO, Waite LJ. Sexual dysfunction among older adults: prevalence and risk factors from a nationally representative U.S. probability sample of men and women 57–85 years of age. J Sex Med. 2008;5(10):2300–2311
   PubMed Web of Science ®Google Scholar
• . American Psychiatric Association. Sexual and gender identity disorders. In: American Psychiatric Association Task Force on DSM-IV, ed. Diagnostic and Statistical Manual of Mental Disorders, 4th ed, text revision [DSM-IV-TR]. Washington, DC: American Psychiatric Association; 2000:535–582
   Google Scholar
• . Brown AD, Blagg J, Reynolds DS. Designing drugs for the treatment of female sexual dysfunction. Drug Discov Today. 2007;12(17–18):757–766
   PubMed Web of Science ®Google Scholar
• . Nurnberg HG. An evidence-based review updating the various treatment and management approaches to serotonin reuptake inhibitor-associated sexual dysfunction. Drugs Today (Barc). 2008;44(2):147–168
   PubMed Web of Science ®Google Scholar
• . Balon R, Segraves RT. Survey of treatment practices for sexual dysfunction(s) associated with anti-depressants. J Sex Marital Ther. 2008;34(4):353–365
   PubMed Web of Science ®Google Scholar
• . Kikuchi T, Uchida H, Suzuki T, Wantanabe K, Kashima H. Patients' attitudes toward side effects of antidepressants: an Internet survey. Eur Arch Psychiatry Clin NeuroSci. 2011;261(2):103–109
   PubMed Web of Science ®Google Scholar
• . Ashton AK, Rosen RC. Bupropion as an antidote for serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry. 1998;59(3):112–115
   PubMed Web of Science ®Google Scholar
• . Serretti A, Chiesa A. Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis. J Clin Psychopharmacol. 2009;29(3):259–266
   PubMed Web of Science ®Google Scholar
• . McGahuey CA, Gelenberg AJ, Laukes CA, Moreno FA, Delgado PL. The Arizona Sexual Experience Scale (ASEX): reliability and validity. J Sex Marital Ther. 2000;26(1):25–40
   PubMed Web of Science ®Google Scholar
• . Clayton AH, McGarvey EL, Clavet GJ. The Changes in Sexual Functioning Questionnaire (CSFQ): development, reliability, and validity. Psychopharmacol Bull. 1997;33(4):731–745
   PubMed Web of Science ®Google Scholar
• . Rizvi SJ, Yeung NW, Kennedy SH. Instruments to measure sexual dysfunction in community and psychiatric populations. J Psychosom Res. 2011;70(1):99–109
   PubMed Web of Science ®Google Scholar
• . Williams K, Reynolds MF. Sexual dysfunction in major depression. CNS Spectr. 2006;11(8 Suppl 9):19–23
   PubMed Web of Science ®Google Scholar
• . Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J Clin Psychiatry. 2001;62( Suppl 3):10–21
   PubMed Web of Science ®Google Scholar
• . Montejo-Gonzàlez AL, Llorca G, Izquierdo JA, . SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther. 1997;23(3):176–194
   PubMed Web of Science ®Google Scholar
• . Angst J. Sexual problems in healthy and depressed persons. Int Clin Psychopharmacol. 1998;13( Suppl 6):S1–S4
   PubMed Web of Science ®Google Scholar
• . Clayton AH, Montejo AL. Major depressive disorder, antidepressants, and sexual dysfunction. J Clin Psychiatry. 2006;67( Suppl 6):33–37
   PubMed Web of Science ®Google Scholar
• . Kennedy SH, Fulton KA, Bagby RM, Greene AL, Cohen NL, Rafi-Tari S. Sexual function during bupropion or paroxetine treatment of major depressive disorder. Can J Psychiatry. 2006;51(4):234–242
   PubMed Web of Science ®Google Scholar
• . Haberfellner EM. A review of the assessment of antidepressant-induced sexual dysfunction used in randomized, controlled clinical trials. Pharmacopsychiatry. 2007;40(5):173–182
   PubMed Web of Science ®Google Scholar
• . Kennedy SH, Eisfeld BS, Dickens SE, Bacchiochi JR, Bagby RM. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine. J Clin Psychiatry. 2000;61(4):276–281
   PubMed Web of Science ®Google Scholar
• . Clayton AH, Pradko JF, Croft HA, . Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry. 2002;63(4):357–366
   PubMed Web of Science ®Google Scholar
• . Williams VS, Edin HM, Hogue SL, Fehnel SE, Baldwin DS. Prevalence and impact of antidepressant-associated sexual dysfunction in three European countries: replication in a cross-sectional patient survey. J Psychopharmacol. 2010;24(4):489–496
   PubMed Web of Science ®Google Scholar
• . Bishop JR, Ellingrod VL, Akroush M, Moline J. The association of serotonin transporter genotypes and selective serotonin reuptake inhibitor (SSRI)-associated sexual side effects: possible relationship to oral contraceptives. Hum Psychopharmacol. 2009;24(3):207–215
   PubMed Web of Science ®Google Scholar
• . Taylor MJ. Strategies for managing antidepressant-induced sexual dysfunction: a review. Curr Psychiatry Rep. 2006;8(6):431–436
   PubMedGoogle Scholar
• . Taylor MJ, Rudkin L, Hawton K. Strategies for managing antidepressant-induced sexual dysfunction: systematic review of randomised controlled trials. J Affect Disord. 2005;88(3):241–254
   PubMed Web of Science ®Google Scholar
• . Clayton A, Kornstein S, Prakash A, Mallinckrodt C, Wohlreich M. Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder. J Sex Med. 2007;4(4 Pt 1):917–929
   PubMed Web of Science ®Google Scholar
• . Clayton AH, Croft HA, Horrigan JP, . Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies. J Clin Psychiatry. 2006;67(5):736–746
   PubMed Web of Science ®Google Scholar
• . Clayton A, Keller A, McGarvey EL. Burden of phase-specific sexual dysfunction with SSRIs. J Affect Disord. 2006;91(1):27–32
   PubMed Web of Science ®Google Scholar
• . Rosen RC, Lane RM, Menza M. Effect of SSRIs on sexual function: a critical review. J Clin Psychopharmacol. 1999;19(1):67–85
   PubMed Web of Science ®Google Scholar
• . Nappi R, Salonia A, Traish AM, . Clinical biologic pathophysiologies of women's sexual dysfunction. J Sex Med. 2005;2(1):4–25
   PubMed Web of Science ®Google Scholar
• . Clayton AH. Sexual function and dysfunction in women. Psychiatr Clin North Am. 2003;26(3):673–682
   PubMed Web of Science ®Google Scholar
• . Basson R, Brotto LA, Laan E, Redmond G, Utian WH. Assessment and management of women's sexual dysfunctions: problematic desire and arousal. J Sex Med. 2005;2(3):291–300
   PubMed Web of Science ®Google Scholar
• . Madeo B, Bettica P, Milleri S, . The effects of citalopram and fluoxetine on sexual behavior in healthy men: evidence of delayed ejaculation and unaffected sexual desire. A randomized, placebo-controlled, double-blind, double-dummy, parallel group study. J Sex Med. 2008;5(10):2431–2441
   PubMed Web of Science ®Google Scholar
• . Suzuki Y, Sawamura K, Someya T. Polymorphisms in the 5-hydroxytryptamine 2A receptor and CytochromeP4502D6 genes synergistically predict fluvoxamine-induced side effects in Japanese depressed patients. Neuropsychopharmacology. 2006;31(4):825–831
   PubMed Web of Science ®Google Scholar
• . Perlis RH, Laje G, Smoller JW, Fava M, Rush AJ, McMahon FJ. Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients. Neuropsychopharmacology. 2009;34(7):1819–1828
   PubMed Web of Science ®Google Scholar
• . Bishop JR, Moline J, Ellingrod VL, Schultz SK, Clayton AH. Serotonin 2A −1438 G/A and G-protein Beta3 subunit C825T polymorphisms in patients with depression and SSRI-associated sexual side-effects. Neuropsychopharmacology. 2006;31(10):2281–2288
   PubMed Web of Science ®Google Scholar
• . Walker PW, Cole JO, Gardner EA, . Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion. J Clin Psychiatry. 1993;54(12):459–465
   PubMed Web of Science ®Google Scholar
• . Masand PS, Ashton AK, Gupta S, Frank B. Sustained-release bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: a randomized, double-blind, placebo-controlled, parallel-group study. Am J Psychiatry. 2001;158(5):805–807
   PubMed Web of Science ®Google Scholar
• . Masand PS, Gupta S. Long-term side effects of newer-generation antidepressants: SSRIs, venlafaxine, nefazodone, bupropion, and mirtazapine. Ann Clin Psychiatry. 2002;14(3):175–182
   PubMedGoogle Scholar
• . DeBattista C, Solvason B, Poirier J, Kendrick E, Loraas E. A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction. J Clin Psychiatry. 2005;66(7):844–848
   PubMed Web of Science ®Google Scholar
• . Thase ME, Clayton AH, Haight BR, Thompson AH, Modell JG, Johnston JA. A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability. J Clin Psychopharmacol. 2006;26(5):482–488
   PubMed Web of Science ®Google Scholar
• . Coleman CC, Cunningham LA, Foster VJ, . Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatment. Ann Clin Psychiatry. 1999;11(4):205–215
   PubMedGoogle Scholar
• . Coleman CC, King BR, Bolden-Watson C, . A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine. Clin Ther. 2001;23(7):1040–1058
   PubMed Web of Science ®Google Scholar
• . Croft H, Settle E Jr, Houser T, Batey SR, Donahue RM, Ascher JA. A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline. Clin Ther. 1999;21(4):643–658
   PubMed Web of Science ®Google Scholar
• . Gelenberg AJ, McGahuey C, Laukes C, . Mirtazapine substitution in SSRI-induced sexual dysfunction. J Clin Psychiatry. 2000;61(5):356–360
   PubMed Web of Science ®Google Scholar
• . Ozmenler NK, Karlidere T, Bozkurt A, . Mirtazapine augmentation in depressed patients with sexual dysfunction due to selective serotonin reuptake inhibitors. Hum Psychopharmacol. 2008;23(4):321–326
   PubMed Web of Science ®Google Scholar
• . Ravindran LN, Eisfeld BS, Kennedy SH. Combining mirtazapine and duloxetine in treatment-resistant depression improves outcomes and sexual function. J Clin Psychopharmacol. 2008;28(1):107–108
   PubMed Web of Science ®Google Scholar
• . Citrome L. Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed? Int J Clin Pract. 2012;66(4):356–368
   PubMed Web of Science ®Google Scholar
• . Robinson DS, Kajdasz DK, Gallipoli S, Whalen H, Wamil A, Reed CR. A 1-year, open-label study assessing the safety and tolerability of vilazodone in patients with major depressive disorder. J Clin Psychopharmacol. 2001;31(5):643–646
   Google Scholar
• . Khan A, Cutler AJ, Kajdasz DK, . A randomized, double-blind, placebo-controlled, 8-week study of vilazodone, a serotonergic agent for the treatment of major depressive disorder. J Clin Psychiatry. 2011;72(4):441–447
   PubMed Web of Science ®Google Scholar
• . Rickels K, Athanasiou M, Robinson DS, Gibertini M, Whalen H, Reed CR. Evidence for efficacy and tolerability of vilazodone in the treatment of major depressive disorder: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2009;70(3):326–333
   PubMed Web of Science ®Google Scholar
• . Rudkin L, Taylor MJ, Hawton K. Strategies for managing sexual dysfunction induced by antidepressant medication. Cochrane Database Syst Rev. 2004(4):CD003382
   Google Scholar
• . Ashton AK, Rosen RC. Accommodation to serotonin reuptake inhibitor-induced sexual dysfunction. J Sex Marital Ther. 1998;24(3):191–192
   PubMed Web of Science ®Google Scholar
• . Hirschfeld RM. Management of sexual side effects of antidepressant therapy. J Clin Psychiatry. 1999;60( Suppl 14):27–30; discussion 31–35
   PubMed Web of Science ®Google Scholar
• . Rothschild AJ. Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday. Am J Psychiatry. 1995;152(10):1514–1516
   PubMed Web of Science ®Google Scholar
• . Clayton AH, McGarvey EL, Abouesh AI, Pinkerton RC. Substitution of an SSRI with bupropion sustained release following SSRI-induced sexual dysfunction. J Clin Psychiatry. 2001;62(3):185–190
   PubMed Web of Science ®Google Scholar
• . Clayton AH, Warnock JK, Kornstein SG, Pinkerton R, Sheldon-Keller A, McGarvey EL. A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry. 2004;65(1):62–67
   PubMed Web of Science ®Google Scholar
• . Zisook S, Rush AJ, Haight BR, Clines DC, Rockett CB. Use of bupropion in combination with serotonin reuptake inhibitors. Biol Psychiatry. 2006;59(3):203–210
   PubMed Web of Science ®Google Scholar